Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 21, 20 December 2023
Open
Access | Article
Current status of drug treatment for hand foot mouth disease
* Author to whom correspondence should be addressed.
Abstract
Hand, foot, and mouth disease (HFMD) is an infectious disease caused by the intestinal RNA virus. Hand, foot, and mouth disease can occur every season, with no significant difference in specificity. However, the more frequent season of onset is spring and summer, with April to September as the main month of onset. Coastal areas are relatively popular areas of incidence. HFMD is mainly characterized by herpes with different sizes and clinical manifestations, such as in the hands, feet, and mouth. This article categorizes drugs into two categories: antiviral drugs and antiviral prevention. In describing antiviral drugs, they are classified them into traditional Chinese medicine and non-traditional Chinese medicine. At the same time, the two most effective and commonly used drugs or methods are summarized for preventing HFMD, namely the EV-71 virus vaccine for HFMD, and the washable hand sanitizer that prevents HFMD by blocking the transmission path of the virus. A comprehensive description and summary of the current treatment methods and drugs for combating and treating HFMD. This article provides a comprehensive description of different drugs by elaborating on their advantages and therapeutic principles, combined with their related pharmacological effects.
Keywords
HFMD, Ribavirin, Interferon Alpha 2b Spray, Xiyanping, Vaccine
References
1. Liu, Z., “The“Three in One”Certification and Accreditation of Testing Laboratories”．. Res. Explor. Lab.,32(5) : 219－-221 (2013)．.
2. Chen,X.,yu,X. wang,G．. “Analysis of Non conformities in the External Audit of the Laboratory Quality Management System of Disease Control and Prevention Institutions in Zhejiang Province”.Chin.J.Health.Lab.Tec, 25(4): 598－-599 (2015).
3. Wang,X. “study on the burden of hand,foot, and mouth disease and the effectiveness evaluation of THE EV-71 vaccine program in BEIJING”[D].Chinese Center for Disease Control and Prevention,10:130 (2019).
4. Solomon T, Lewthwaite P, Perera D, et al. “Virology, epidemiology,pathogenesis,and control of enterovirus 71”.Lancet Infect Dis.10(11):778-790 (2010).
5. Thompson SR, Sarnow P. “Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G isCleaved”. Virology. 10;315(1):259–266 (2003).
6. Kok CC, Phuektes P, Bek E,. “Modification of the untranslatedregions of human enterovirus 71 impairs growth in a cell-specificManner”. J Virol. 86(1):542–552 (2012).
7. National Health Commission of the People's Republic of China.”Diagnosis and Treatment Guidelines for Hand, Foot, and Mouth Disease”.Nation. Health Commis. Chin.39(4):257-263 (2018).
8. yin,M.”The clinical effect of combination of Reduning and interferon in the treatment of hand, foot,and mouth disease in children”. Clinical Med. Res. Pract.5(34):147-149 (2020).
9. Ji,T.,Feng,X.,Zheng,L.”Meta analysis of Kangfuxin liquid combined with interferon in the treatment of hand, foot, and mouth disease in children”.Modern Med. Health,39(04):605-609 (2013).
10. Weeramanthri TS, Dawkins HJS, Baynam G,et al.”Frontiers in Public Health”.Precision Public Health.6:121., 17 (2021).
11. Hu,Y.,Liu,L.,Liu,J.“Research progress on the pharmacological effects of ribavirin”. J. Jilin Medl Colleg.43(03):208-212 (2022).
12. Chen,H.,chen,X.,zhou,J.“Recombinant human interferon α - Effect of 2b spray on immune function of children with hand foot mouth disease”. Chin. J. Hospital Infect. 29(10): 1562 - 1566 (2019).
13. Zhao,C.,zhao,S. “Epidemic situation and response strategies of hand, foot, and mouth disease”.Chin. J. Pract. Pediatrics.24(6):419 (2019).
14. Liu,F. “The therapeutic effect of total sulfonated andrographolide (Xiyanping injection) on pediatric hand, foot, and mouth disease“.Capital Med. 21(04):36 (2014).
15. Liu,W.“Clinical Effect and Safety Analysis of Qingwen Baidu Decoction Combined with Fumigation and Washing with Traditional Chinese Medicine in the Treatment of Damp-heat and Steaming Type of Hand-foot-mouth Disease in Children”. Guide Chin. Med.21(03):132-135(2013).
16. Wu,D. “Observation on the therapeutic effect of Yinqiao Haoqin decoction combined with traditional Chinese medicine acupoint application on children with hand, foot, and mouth disease”. Shenzhen J. Integr. Tradit. Chin. West. Med.30(10):55-56(2020).
17. Chen,J.“Observation on the effect of Xiyanping injection combined with traditional Chinese medicine fumigation and washing in the treatment of hand, foot, and mouth disease in children”. Contemp. Med. 22(36):188-189(2016).
18. Ma H Q,Wang Y,Mao Y H,et al.“ The inactivation of the non - enveloped enterovirus 71 ( EV71) by a novel disinfectant gel formulation for topical use”. Drug Dev Ind Pharm.45 ( 3) : 506-513(2019).
19. Zhao,J. “System Biology Study on the Immune Mechanism of EV71 Whole Virus Inactivated Vaccine”.Jilin University.(08):112,(2016).
20. Luo Y,Fu J,Pan X J, et al. “Post-marketing safety analysis of inactivated enterovirus A71 vaccines”. Chin. J prev. med.,53(3).(2019).
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-215-2
- ISBN (Online)
- 978-1-83558-216-9
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/21/20230805
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited